Results
- Showing results for:
- Reset all filters
Search results
-
Conference paperMorar N, Harper J, Cookson WO, et al., 2006,
Filaggrin mutations in atopic dermatitis
, 36th Annual Meeting of the European-Society-of-Dermatology-Research (ESDR), Publisher: NATURE PUBLISHING GROUP, Pages: 38-38, ISSN: 0022-202X -
Journal articleLau QC, Raja E, Salto-Tellez M, et al., 2006,
RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.
, Cancer Res, Vol: 66, Pages: 6512-6520, ISSN: 0008-5472A tumor suppressor function has been attributed to RUNX3, a member of the RUNX family of transcription factors. Here, we examined alterations in the expression of three members, RUNX1, RUNX2, and RUNX3, and their interacting partner, CBF-beta, in breast cancer. Among them, RUNX3 was consistently underexpressed in breast cancer cell lines and primary tumors. Fifty percent of the breast cancer cell lines (n = 19) showed hypermethylation at the promoter region and displayed significantly lower levels of RUNX3 mRNA expression (P < 0.0001) and protein (P < 0.001). In primary Singaporean breast cancers, 9 of 44 specimens showed undetectable levels of RUNX3 by immunohistochemistry. In 35 of 44 tumors, however, low levels of RUNX3 protein were present. Remarkably, in each case, protein was mislocalized to the cytoplasm. In primary tumors, hypermethylation of RUNX3 was observed in 23 of 44 cases (52%) and was undetectable in matched adjacent normal breast epithelium. Mislocalization of the protein, with or without methylation, seems to account for RUNX3 inactivation in the vast majority of the tumors. In in vitro and in vivo assays, RUNX3 behaved as a growth suppressor in breast cancer cells. Stable expression of RUNX3 in MDA-MB-231 breast cancer cells led to a more cuboidal phenotype, significantly reduced invasiveness in Matrigel invasion assays, and suppressed tumor formation in immunodeficient mice. This study provides biological and mechanistic insights into RUNX3 as the key member of the family that plays a role in breast cancer. Frequent protein mislocalization and methylation could render RUNX3 a valuable marker for early detection and risk assessment.
-
Journal articleReed A, Snell GI, McLean C, et al., 2006,
Outcomes of patients with interstitial lung disease referred for lung transplant assessment.
, Intern Med J, Vol: 36, Pages: 423-430BACKGROUND: Patients with interstitial lung disease (ILD) very frequently die before the opportunity to receive lung transplantation (LTx). This retrospective study describes the clinical course of 86 patients with ILD referred for LTx assessment between January 1999 and December 2002. AIMS: (i) To describe the outcomes, (ii) to identify reasons of delay to transplantation, (iii) to describe the causes of death/complications and (iv) to assess the pathological diagnosis and concordance with explanted lung pathology. METHODS: Data were collected from the case notes of all patients with ILD referred to the Alfred Hospital over a 4-year period. RESULTS: Twenty women and 66 men, mean age of 55 +/- 8 years, were referred for LTx assessment. Forty-five patients were deemed not suitable for LTx and 41 were listed. Twenty-two patients underwent transplantation, 16 died on the waiting list and 7 are still on the waiting list. Complications were frequent (e.g. pulmonary embolism, malignancy and infection) and carried high mortality. Patients dying on the waiting list appeared generally to be in accelerated decline, dying shortly after listing, with no evidence in their lung function test assessment predicting them as a poor prognosis group. CONCLUSIONS: Serious complications and death on the waiting list of patients with idiopathic pulmonary fibrosis are high, not apparently because of delayed referral but usually in patients undergoing very rapid decline.
-
Conference paperGarvey JP, Chotirmall SH, Dorman A, et al., 2006,
Co-trimoxazole induced acute interstitial nephritis in renal allografts: Clinical course and outcome
, 43rd Annual Congress of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA), Publisher: OXFORD UNIV PRESS, Pages: 523-523, ISSN: 0931-0509 -
Conference paperGarvey JP, Chotirmall SH, Curran S, et al., 2006,
Sirolimus in chronic allograft nephropathy
, 43rd Annual Congress of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA), Publisher: OXFORD UNIV PRESS, Pages: 268-268, ISSN: 0931-0509 -
Journal articleMorar N, Willis-Owen SAG, Moffatt MF, et al., 2006,
The genetics of atopic dermatitis
, JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, Vol: 118, Pages: 24-34, ISSN: 0091-6749- Author Web Link
- Cite
- Citations: 194
-
Journal articleGriesenbach U, Geddes DM, Alton EWFW, 2006,
Gene therapy progress and prospects: cystic fibrosis
, GENE THERAPY, Vol: 13, Pages: 1061-1067, ISSN: 0969-7128- Author Web Link
- Cite
- Citations: 72
-
Journal articleHaibach K, Menner A, Powell R, et al., 2006,
Tailoring mechanical properties of highly porous polymer foams: Silica particle reinforced polymer foams via emulsion templating
, POLYMER, Vol: 47, Pages: 4513-4519, ISSN: 0032-3861- Author Web Link
- Cite
- Citations: 152
-
Journal articleTanabe M, Atkins HS, Harland DN, et al., 2006,
The ABC transporter protein OppA provides protection against experimental <i>Yersinia pestis</i> infection
, INFECTION AND IMMUNITY, Vol: 74, Pages: 3687-3691, ISSN: 0019-9567- Author Web Link
- Cite
- Citations: 58
-
Journal articleAdcock IM, Caramori G, Ito K, 2006,
New insights into the molecular mechanisms of corticosteroids actions
, CURRENT DRUG TARGETS, Vol: 7, Pages: 649-660, ISSN: 1389-4501- Author Web Link
- Cite
- Citations: 33
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.
General enquiries
For any enquiries about the Fungal Science Network at Imperial, please contact: